Skip to main content

Published locations for FDA panel backs Brintellix for cognitive dysfunction in depression

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel backs Brintellix for cognitive dysfunction in depression

User login

  • Reset your password
  • /content/fda-panel-backs-brintellix-cognitive-dysfunction-depression
  • /familypracticenews/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction
  • /internalmedicinenews/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction
  • /psychiatry/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction-depression
  • /internalmedicine/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction
  • /neurology/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction-depression
  • /familymedicine/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction-depression
  • /clinicalneurologynews/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction
  • /clinicalpsychiatrynews/article/106322/depression/fda-panel-backs-brintellix-cognitive-dysfunction